Tracks
Related Products
POSTOPERATIVE DAY 1 DRAIN AMYLASE AFTER PANCREATICODUODENECTOMY: DOES IT CHANGE THE FISTULA RISK PROFILE?
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
ROBOTIC PORTAL LYMPHADENECTOMY WITH PARTIAL CENTRAL HEPATECTOMY FOR GALLBLADDER CARCINOMA: TECHNIQUE OF VASCULAR HANDLING & HEMOSTASIS IN MINIMALLY INVASIVE APPROACH
Gallbladder carcinoma (GBC) is uncommon and aggressive, generally with poor prognosis…
PAVING A PATH TO GENDER PARITY: RECENT TRENDS IN PARTICIPATION OF WOMEN IN AN ACADEMIC SURGERY SOCIETY
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
NEOADJUVANT THERAPY REDUCES NODE POSITIVITY BUT DOES NOT CONFER SURVIVAL BENEFIT VERSUS UP-FRONT RESECTION FOR RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA: A PROPENSITY-MATCHED ANALYSIS
Intrahepatic Cholangiocarcinoma (iCCA) is rare but deadly. Neoadjuvant systemic therapy (NAST) is frequently employed, though its’ impact on short-term oncologic outcomes and/or survival remains relatively unknown…
